NFKB1 and lung carcinoma: Similarly, as in population-level modeling, there is an open question about the similarity in dynamics and structure of intracellular pathway models developed for other cancer types (particularly p53, NF-κB, Wnt, or NRF2 pathway models, important for chemoresistance) and their analogues in lung cancer.